198 related articles for article (PubMed ID: 35613543)
1. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D-dimer results.
Miyake R; Yamada Y; Yamanaka S; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
Mol Clin Oncol; 2022 Feb; 16(2):46. PubMed ID: 35003744
[TBL] [Abstract][Full Text] [Related]
3. Preoperative plasma D-dimer level is a useful prognostic marker in ovarian cancer.
Yamada Y; Kawaguchi R; Iwai K; Niiro E; Morioka S; Tanase Y; Kobayashi H
J Obstet Gynaecol; 2020 Jan; 40(1):102-106. PubMed ID: 31335252
[TBL] [Abstract][Full Text] [Related]
4. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of risk factors for venous thromboembolism in Chinese women with epithelial ovarian cancer.
Wu X; Xue X; Tang J; Cheng X; Tian W; Jiang R; Zang R
Int J Gynecol Cancer; 2013 Jan; 23(1):65-72. PubMed ID: 23196757
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
[TBL] [Abstract][Full Text] [Related]
8. Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.
Miyagi E; Arakawa N; Sakamaki K; Yokota NR; Yamanaka T; Yamada Y; Yamaguchi S; Nagao S; Hirashima Y; Kasamatsu Y; Kato H; Mogami T; Miyagi Y; Kobayashi H
Int J Clin Oncol; 2021 Jul; 26(7):1336-1344. PubMed ID: 34009487
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors.
Kobayashi H; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kimura F
J Obstet Gynaecol Res; 2022 Sep; 48(9):2442-2451. PubMed ID: 35778814
[TBL] [Abstract][Full Text] [Related]
10. The Usefulness of the Combination of D-Dimer and Soluble Fibrin Monomer Complex for Diagnosis of Venous Thromboembolism in Psychiatric Practice: A Prospective Study.
Takeshima M; Ishikawa H; Ogasawara M; Komatsu M; Fujiwara D; Itoh Y; Wada Y; Omori Y; Ohta H; Mishima K
Vasc Health Risk Manag; 2021; 17():239-246. PubMed ID: 34054298
[TBL] [Abstract][Full Text] [Related]
11. The Combination of D-dimer and Glasgow Prognostic Score Can Be Useful in Predicting VTE in Patients with Stage IIIC and IVA Ovarian Cancer.
Kubo K; Nakamura K; Okamoto K; Matsuoka H; Ida N; Haruma T; Ogawa C; Masuyama H
Acta Med Okayama; 2022 Apr; 76(2):129-135. PubMed ID: 35503440
[TBL] [Abstract][Full Text] [Related]
12. Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma.
Arakawa N; Miyagi E; Nomura A; Morita E; Ino Y; Ohtake N; Miyagi Y; Hirahara F; Hirano H
J Proteome Res; 2013 Oct; 12(10):4340-50. PubMed ID: 23805888
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
Wang Y; Zhou H; Zhong G; Fu Z; Peng Y; Yao T
Clin Appl Thromb Hemost; 2022; 28():10760296221095558. PubMed ID: 35549519
[TBL] [Abstract][Full Text] [Related]
14. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.
Cheng Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Zhang W; Wu J
Clin Appl Thromb Hemost; 2019; 25():1076029619877458. PubMed ID: 31608652
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a D-Dimer Protocol for Detection of Venous Thromboembolism.
Karsy M; Azab MA; Harper J; Abou-Al-Shaar H; Guan J; Eli I; Brock AA; Ormond RD; Hosokawa PW; Gouripeddi R; Butcher R; Cole CD; Menacho ST; Couldwell WT
World Neurosurg; 2020 Jan; 133():e774-e783. PubMed ID: 31605841
[TBL] [Abstract][Full Text] [Related]
17. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism.
Curtin N; Highe G; Harris M; Braunstein A; Demattia F; Coss L
Lab Hematol; 2004; 10(2):88-94. PubMed ID: 15224764
[TBL] [Abstract][Full Text] [Related]
18. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract][Full Text] [Related]
19. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
Man YN; Wang YN; Hao J; Liu X; Liu C; Zhu C; Wu XZ
Int J Gynecol Cancer; 2015 Jan; 25(1):24-32. PubMed ID: 25347092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
